Marksans Pharma up 20 percent after inspection wind-up at Goa plant
New Delhi : Marksans Pharma zoomed 20 per cent after the company said inspection by the UK health regulator at its Goa plant has been completed without any critical observations.
The stock skyrocketed 19.95 per cent to end at Rs 48.70 on BSE.
On NSE, it soared 20 per cent to close at Rs 48.60.
The company added Rs 332.36 crore to Rs 1,993.36 crore in market valuation.
On the volume front, 92.82 lakh shares of the company were traded on the BSE and over 4 crore shares changed hands on the NSE during the day.
The plant located at Verna has had an inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA) from February 14-17, Marksans Pharma said in a BSE filing.
"The same has been completed without any critical observations," it added.
The company, which makes formulations at the facility, is awaiting further instruction from the agency in this regard, Marksans Pharma said.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd